{"id":5484,"date":"2025-03-14T23:12:12","date_gmt":"2025-03-14T22:12:12","guid":{"rendered":"https:\/\/johann-strauss-apotheke.at\/?p=5484"},"modified":"2025-08-07T10:26:41","modified_gmt":"2025-08-07T08:26:41","slug":"hiv-prep","status":"publish","type":"post","link":"https:\/\/johann-strauss-apotheke.at\/en\/hiv-prep\/","title":{"rendered":"HIV PrEP for trans, non-binary and inter people"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t

Self-determined protection with PrEP<\/h1>\n

For trans, non-binary and inter people<\/h3>\n

HIV-negative trans, non-binary and inter people have the opportunity to effectively protect themselves from infection with HIV pre-exposure prophylaxis (HIV PrEP). This medication prevents HIV from multiplying in the body if it is contracted through sexual contact. The effectiveness of PrEP is independent of whether hormones have been taken or sex reassignment surgery has been performed. A major advantage of HIV PrEP is that the HIV-negative person has control over their own protection and can organise it independently.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div>

\n\t
\n\t\t\n\t\t
\n\t\t\t
\"HIV<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div><\/div>
\n\t
\n\t\t\n\t\t
\n\t\t\t
\"An<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t

How is HIV transmitted?<\/h2>\n

HIV is transmitted through bodily fluids such as blood, semen, anal secretions and anterior secretions, especially when the viral load is high. Infection occurs when these fluids come into contact with mucous membranes or minor injuries in the anal or genital area. Sharing needles also harbours a high risk, as infected blood can be transmitted directly.<\/p>\n

Oral sex carries a very low risk, as the oral mucosa usually fends off the virus. There is only an increased risk with open wounds or bleeding gums. Protective measures such as condoms or dental dams further reduce the risk.<\/p>\n

Modern therapies such as PrEP and ART significantly reduce the risk of infection. Successful antiretroviral therapy can reduce the viral load below the detection limit (\u201eU=U\u201c), which means that HIV is no longer transmissible. Regular testing helps to recognise infections at an early stage and prevent further transmission.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>

\n\t
\n\t\t
\n\t\t\t

The right way to take HIV PrEP<\/h2>\n

For HIV PrEP to work effectively, a sufficient level of the active substance must be built up in the body. There is a clear intake strategy for this:<\/p>\n

Lead-in phase (start of HIV PrEP intake)<\/h3>\n

To ensure the protective effect, 2 tablets are taken 24 to 2 hours before the first sexual contact. A further tablet is then taken at around the same time each day. This ensures that protection is maintained throughout.<\/p>\n

While taking HIV PrEP, regular HIV tests should be carried out in order to recognise a possible infection at an early stage. This allows for immediate treatment if an infection is detected. It is also important to have regular medical check-ups in order to avoid the development of resistance to the medication.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div>

\n\t
\n\t\t\n\t\t
\n\t\t\t
\"PrEP<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div><\/div>
\n\t
\n\t\t\n\t\t
\n\t\t\t
\"PrEP<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t

Lead-out phase (ending HIV PrEP)<\/h3>\n

When HIV PrEP is discontinued, care must be taken to ensure that the drug level does not drop too soon. The necessary period depends on the physical configuration:<\/p>\n

Dx2 scheme (taken 2 days after the last sex)<\/strong><\/p>\n